Nevertheless, Zetterberg et al. showed that higher CSF NF-L concentrations are associated with cognitive deterioration and brain atrophy over time in AD and MCI groups, indicating that CSF NF-L can be used as a marker for AD progression [49]. The gene discussed is NEFL; the disease is Brain atrophy.